Home > Insider Trading > Filing (0001209191-21-031638)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1810182	Alx Oncology Holdings Inc	ALXO	Pharmaceutical Preparations (2834)	850642577

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1817127	Sophia Randolph	C/O Alx Oncology Holdings Inc. 866 Malcolm Road, Suite 100 Burlingame CA 94010	Chief Medical Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-05-10	1,925	$61.12	191,825	No	4	S	Direct
Common Stock	Disposition	2021-05-10	4,433	$62.12	187,392	No	4	S	Direct
Common Stock	Disposition	2021-05-10	956	$62.79	186,436	No	4	S	Direct
Common Stock	Disposition	2021-05-10	73	$64.56	186,363	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.61 to $61.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.64 to $62.59, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.64 to $63.13, inclusive.